FTI Consulting, Inc.

FCN Details

FTI Consulting, Inc. (NYSE: FCN) is a global business advisory company helping organizations manage change, minimize risk, and resolve disputes. The Company operates through five segments: Corporate Finance & Restructuring, Forensic and Litigation Consulting, Economic Consulting, Technology and Strategic Communications.

Result Performance (Q2FY21 ended 30 June 2021)

• Revenues for the period stood at $711.49 million, increasing by 3.7% QoQ and 17.0% YoY, whereby, revenues from Corporate Finance & Restructuring declined by 6.1% YoY, while  revenues from Forensic and Litigation Consulting, Economic Consulting, Technology and Strategic Communications, was up by 41.7%, 21.0%, 67.0% and 19.2% YoY, respectively.
• Consolidated Net Income for the period stood at $62.78 million, as compared to $48.17 million in the previous corresponding period.
• Adjusted EBITDA for the period stood at $92.31 million, as compared to $75.80 million in the pcp.

Key Data (Source: Company Reports)

Outlook:

The company has offices in 86 cities and 29 countries thus, has a presence across the globe that provides opportunities as well as challenges. The management believes that there would be increased growth momentum across segments in upcoming years, thereby, helping the company to generate value for its shareholders.

FY21 Guidance: Revenue for FY21 has been anticipated between $2,700-$2,800 million. Earnings Per Diluted Share for FY21 has been anticipated between $5.89-$6.39. Adjusted Earnings Per Diluted Share for FY21 has been anticipated between $6.00-$6.50.

Key Risks:

Increasing competition and risks relating to cybersecurity may put revenues and margins under pressure. Further, changes in capital markets, legal requirements, monetary or geopolitical disruptions, might reduce demand for FCN’s offerings.

Valuation Methodology: EV/EBITDA Based Relative Valuation (Illustrative)

Stock Recommendation:

The company’s EBITDA margin and net margin for Q2FY21 stood at 13.4% and 8.8%, better than the industry median of 12.7% and 6.1%, respectively, implying an improvement in margins  for the company. The stock rose by ~21.99% in 9 months. The stock has been valued using an EV/EBITDA multiple- based illustrative relative valuation method and  a target price which reflects a fall of high single-digit (in % terms) has been arrived. The company might trade at a slight discount to EV/EBITDA Multiple (NTM)  (Peer Average) considering fall in the cash and cash equivalents in Q2 FY 2021 on the YoY basis as well as risks associated.

The stock is trading towards the 52-week higher levels and, therefore, we advise the investors to liquidate the stock.

Thus, we give a “Sell” rating on the stock at the current market price of $138.01 per share (Time: 12:36 PM, NY, US) on 17^th September 2021.  

Technical Overview:

Chart:

Source: REFINITIV

Note: Purple Color Line Reflects RSI (14-Period)

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.